Teva Pharmaceutical Industries (TEVA) Share-based Compensation Growth (1y) (2010 - 2026)
Teva Pharmaceutical Industries (TEVA) Share-based Compensation Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.79 Bn | 86.92 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn | 26.47% |
| 3 | Zoetis | 32.11 Bn | 30.17 Bn | 1.62 Bn | 47.06% |
| 4 | Takeda Pharmaceutical | 27.45 Bn | 23.38 Bn | 4.39 Bn | 8.79% |
| 5 | United Therapeutics | 23.26 Bn | 21.10 Bn | 648.10 Mn | 281.05% |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.21 Bn | 18.41 Bn | 1.16 Bn | 92.83% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.48 Bn | 800.70 Mn | 5.49% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 61.54% |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 438.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.47% |
| Dec 31, 2025 | 50.00% |
| Sep 30, 2025 | 17.24% |
| Jun 30, 2025 | 18.75% |
| Mar 31, 2025 | 21.43% |
| Dec 31, 2024 | 21.43% |
| Sep 30, 2024 | -6.45% |
| Jun 30, 2024 | 6.67% |
| Mar 31, 2024 | -12.50% |
| Dec 31, 2023 | -22.22% |
| Sep 30, 2023 | 19.23% |
| Jun 30, 2023 | -23.08% |
| Mar 31, 2023 | 33.33% |
| Dec 31, 2022 | 9.09% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 34.48% |
| Mar 31, 2022 | -22.58% |
| Dec 31, 2021 | -13.16% |
| Sep 30, 2021 | -10.34% |
| Jun 30, 2021 | -9.38% |